Hence, our results indicate that potential prognostic value of (lipid) sulfatide, as an abundant and in part immunomodulating component of RCC microenvironment, cannot be translated to (enzyme / protein) Gal3ST1 levels in tumor cells. The gene discussed is GAL3ST1; the disease is neoplasm.